Weekly Adriamycin vs. 4-epidoxorubicin every second week in advanced breast cancer. A randomized trial. The Norwegian Breast Cancer Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples